← Back to Analyst Consensus 
AHCO Buy
AdaptHealth Corp.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (7 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 17, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Aug 6, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 5, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 21, 2026 | Jefferies | upgrade | Hold → Buy | — | 52% |
| Jul 6, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| May 11, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 6, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 6, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 13, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Feb 26, 2026 | Leerink Partners | maintain | Outperform → Outperform | $12 | 51% |
| Nov 6, 2025 | Canaccord Genuity | maintain | Buy → Buy | $15 | 48% |
| May 12, 2025 | Truist Securities | maintain | Buy → Buy | $13 | 54% |
| May 8, 2025 | RBC Capital | maintain | Outperform → Outperform | $13 | 55% |
| Feb 27, 2025 | Baird | maintain | Outperform → Outperform | $16 | 55% |
| Feb 26, 2025 | Canaccord Genuity | maintain | Buy → Buy | $14 | 48% |
| Feb 26, 2025 | RBC Capital | maintain | Outperform → Outperform | $14 | 55% |
| Feb 26, 2025 | Truist Securities | maintain | Buy → Buy | $14 | 54% |
| Feb 13, 2025 | UBS | maintain | Buy → Buy | $11 | 54% |
| Nov 19, 2024 | RBC Capital | maintain | Outperform → Outperform | $11 | 55% |
| Nov 15, 2024 | Truist Securities | maintain | Buy → Buy | $12 | 54% |
| Nov 6, 2024 | UBS | maintain | Buy → Buy | $12 | 54% |
| Nov 6, 2024 | Canaccord Genuity | maintain | Buy → Buy | $13 | 48% |
| Nov 6, 2024 | Baird | maintain | Outperform → Outperform | $14 | 55% |
| Aug 12, 2024 | RBC Capital | reiterate | Outperform → Outperform | $13 | 55% |
| May 15, 2024 | Truist Securities | maintain | Buy → Buy | $13 | 54% |
| Mar 4, 2024 | RBC Capital | reiterate | Outperform → Outperform | $13 | 55% |
| Feb 28, 2024 | UBS | maintain | Buy → Buy | $13 | 54% |
| Feb 28, 2024 | Truist Securities | maintain | Buy → Buy | $13 | 54% |
| Jan 29, 2024 | UBS | maintain | Buy → Buy | $9 | 54% |
| Nov 8, 2023 | RBC Capital | maintain | Outperform → Outperform | $13 | 55% |
| Nov 8, 2023 | B of A Securities | downgrade | Neutral → Underperform | $6.5 | 53% |
| Nov 8, 2023 | Truist Securities | maintain | Buy → Buy | $11 | 54% |
| Oct 11, 2023 | Truist Securities | maintain | Buy → Buy | $14 | 54% |
| Sep 22, 2023 | B of A Securities | maintain | Neutral → Neutral | $11 | 53% |
| Jul 13, 2023 | Baird | maintain | Outperform → Outperform | $21 | 55% |
| Jun 28, 2023 | Baird | reiterate | Outperform → Outperform | $20 | 55% |
| Jun 27, 2023 | Baird | reiterate | Outperform → Outperform | $20 | 55% |
| May 11, 2023 | RBC Capital | maintain | Outperform → Outperform | $18 | 55% |
| May 10, 2023 | Canaccord Genuity | maintain | Buy → Buy | $17 | 48% |
| May 10, 2023 | Truist Securities | maintain | Buy → Buy | $15 | 54% |
| May 10, 2023 | Baird | maintain | — → Outperform | $20 | 55% |
| May 10, 2023 | Deutsche Bank | downgrade | Buy → Hold | $11.3 | 57% |
| May 10, 2023 | Stifel | downgrade | Buy → Hold | $11 | 54% |
| May 9, 2023 | B of A Securities | downgrade | Buy → Neutral | $12 | 53% |
| Apr 13, 2023 | Truist Securities | maintain | — → Buy | $17 | 54% |
| Mar 1, 2023 | Baird | maintain | — → Outperform | $23 | 55% |
| Nov 10, 2022 | SVB Leerink | maintain | — → Outperform | $30 | — |
| Sep 20, 2022 | Deutsche Bank | maintain | — → Buy | $28 | 57% |
| Sep 19, 2022 | Truist Securities | maintain | — → Buy | $28 | 54% |
Price Target Trend
May 7, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days